Apellis Pharmaceuticals Insider Trades

APLS

Track insider trading activity from Apellis Pharmaceuticals executives and directors. See which insiders are buying and selling APLS stock.

Trades Last 12 Months

APLS Price

All Insider Trades for Apellis Pharmaceuticals

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$236k 5,748 shares
$41.03
$41.03
Wheeler Craig A Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$327k 7,961 shares
$41.03
$41.03
Baumal Caroline Chief Medical Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$3.55M 86,525 shares
$41.03
$41.03
Boucher Kelley Chief People Officer
Holding Value $1.24M 30,146 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.86M 45,219 shares
$41.03
$41.03
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$6.63M 161,567 shares
$41.03
$41.03
Fonteyne Paul R. Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.54M 37,500 shares
$41.03
$41.03
Francois Cedric Chief Executive Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$77.7M 1,893,658 shares
$41.03
$41.03
Sullivan Timothy Eugene Chief Financial Officer
Holding Value $2.39M 58,140 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.53M 159,080 shares
$41.03
$41.03
Machiels Alec Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$10.1M 245,844 shares
$41.03
$41.03
Meltzer Leslie Chief Research And Development
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.86M 45,220 shares
$41.03
$41.03
Nicholson Nur Chief Technical Officer
Holding Value $1.86M 45,220 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.47M 133,364 shares
$41.03
$41.03
Watson David O. General Counsel
Holding Value $2.3M 55,986 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.31M 153,737 shares
$41.03
$41.03
Chan Gerald Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$1.05M 25,666 shares
$41.03
$41.03
Chopas James George Vp/chief Accounting Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$2.71M 65,955 shares
$41.03
$41.03
Walbert Keli Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$700k 17,051 shares
$41.03
$41.03
De Long Mark Jeffrey Chief Business & Strat Officer
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$4.7M 114,591 shares
$41.03
$41.03
Deschatelets Pascal Chief Scientific Officer
Holding Value $1.69M 41,250 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.69M 90,040 shares
$41.03
$41.03
Dolsten Mikael Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$587k 14,312 shares
$41.03
$41.03
Delong Mark Jeffrey Chief Business & Strat Officer
Holding Value $3.38M 82,500 shares
Last Trade
Jun 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.6M 82,500 shares
$19.39
$41.03
Townsend Adam J. Chief Commercial Officer
Holding Value $3.45M 84,050 shares
Last Trade
Jan 29, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$20.5k 695 shares
$29.52
$41.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up